- My Forums
- Tiger Rant
- LSU Recruiting
- SEC Rant
- Saints Talk
- Pelicans Talk
- More Sports Board
- Coaching Changes
- Fantasy Sports
- Golf Board
- Soccer Board
- O-T Lounge
- Tech Board
- Home/Garden Board
- Outdoor Board
- Health/Fitness Board
- Movie/TV Board
- Book Board
- Music Board
- Political Talk
- Money Talk
- Fark Board
- Gaming Board
- Travel Board
- Food/Drink Board
- Ticket Exchange
- TD Help Board
Customize My Forums- View All Forums
- Show Left Links
- Topic Sort Options
- Trending Topics
- Recent Topics
- Active Topics
Started By
Message
re: AUPH - Aurinia Pharmaceuticals
Posted on 12/6/19 at 9:58 am to Aug1
Posted on 12/6/19 at 9:58 am to Aug1
quote:Yep! The longer they wait the higher the buyout would have to be.
I imagine it will come in Q3 after the P3 dry eye trial is completed. Biggest bang for the buck if it is successful. Readout is expected in Q2 then another quarter for BO
2
Posted on 12/6/19 at 10:05 am to bayoubengals88
I sure do appreciate you bringing this to the board. I have a good amount at less than $5.00 a share. Was going to sell half but decided to hold. I dipped into SRNE at $3.34 this morning and will double up if it gets below $3. Thanks for your insight
Posted on 12/6/19 at 11:41 am to bayoubengals88
Nice red to green day for auph. Great to see that
Posted on 12/6/19 at 11:49 am to thatguy777
quote:Indeed!
Nice red to green day for auph. Great to see that
Check out what happened after phase 2:
edit: The drop off after 10.54 was a direct effect of the public offering, which should not be needed this time.
This post was edited on 12/6/19 at 11:53 am
Posted on 12/6/19 at 12:52 pm to bayoubengals88
are you the stock expert on this board dude? trying to drop a couple Gs into something risky. please give me some ideas
Posted on 12/6/19 at 12:57 pm to Mr Perfect
quote:No, but you should probably read my posts on AUPH back about 2-3 pages and make a decision on it.
are you the stock expert on this board dude?
A lot of people have already made good money, and I think there's a good thesis for 100-200% increase from here.
This post was edited on 12/6/19 at 1:02 pm
Posted on 12/6/19 at 2:21 pm to jerryc436
AUPH's twin?? similar market cap, same area of the body, similar public offering, but this one already has an fda approved drug and is 84% institutionally owned!
Ardelyx Website
ARDX
LINK
Ardelyx Website
ARDX
quote:
FREMONT, Calif., Dec. 4, 2019 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a specialized biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with cardiorenal diseases, today announced the pricing of an underwritten public offering of 20,000,000 shares of its common stock at a public offering price of $6.25 per share, before underwriting discounts and commissions, for gross proceeds of $125,000,000. In addition, Ardelyx has granted the underwriters of the offering the right for a period of 30 days to purchase up to an additional 3,000,000 shares of common stock at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about December 9, 2019, subject to customary closing conditions.
Ardelyx currently expects to use its existing cash, cash equivalents and short-term investments and the net proceeds from the offering to support its activities for the clinical development and potential commercialization of tenapanor for the treatment of hyperphosphatemia in patients with chronic kidney disease, or CKD, on dialysis, for regulatory activities to support the submission of a New Drug Application, in such indication, as well as for clinical trials and nonclinical studies for other product candidates, and for general corporate purposes and working capital.
LINK
This post was edited on 12/6/19 at 2:25 pm
Posted on 12/6/19 at 2:31 pm to bayoubengals88
PULM is a good play this week
Posted on 12/6/19 at 2:54 pm to Paul Allen
Deleted it from my watchlist just this morning.Posted on 12/6/19 at 2:56 pm to bayoubengals88
quote:
Deleted it from my watchlist just this morning
A bit premature if you ask me. It’s a steal at $0.87
Posted on 12/6/19 at 3:16 pm to Paul Allen
It’s got a pretty bad track record since you first mentioned it around $4.
Thankfully I only lost a few bucks!
The data never clicked with me.
I don’t know it so I don’t own it
Thankfully I only lost a few bucks!
The data never clicked with me.
I don’t know it so I don’t own it
Posted on 12/6/19 at 5:17 pm to bayoubengals88
quote:
I haven't touched a share. I'm long AUPH.
They'll either continue to develop and commercialize much needed drugs, or they will get bought out.
I’m with you. We could see a pullback if/when they decide to sell some stock and raise some more cash, but outside of that, it seems primed for a bright future.
Posted on 12/8/19 at 3:47 pm to TheChosenOne
quote:if/when is a good way to put it...
We could see a pullback if/when they decide to sell some stock and raise some more cash,
If it does happen I’ll have to buy a few more shares.
Posted on 12/8/19 at 4:50 pm to bayoubengals88
dude. thanks for advice. please updated the us all if there is a pullback. I'm waiting for a buying opportunity
Posted on 12/8/19 at 5:44 pm to Mr Perfect
I’ll be happy to update you, but also a bit perplexed as to how that could be your quickest method of news 
Posted on 12/9/19 at 7:53 am to bayoubengals88
Well apparently it's happening now.... AUPH raising more money. Can't wait to see if it gets hammered.
quote:
VICTORIA, British Columbia--(BUSINESS WIRE)-- Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today announced that it has commenced a registered underwritten public offering of US$150,000,000 of its common shares (the “Offering”).
Jefferies LLC and SVB Leerink LLC are acting as joint book-running managers for the Offering. H.C. Wainwright & Co. LLC, Oppenheimer & Co. Inc., and Bloom Burton Securities Inc. are acting as co-managers for the Offering.
The Company will grant the underwriters an option exercisable, in whole or in part, in the sole discretion of the underwriters, to purchase up to an aggregate of US$22,500,000 of additional shares, for a period of up to 30 days. The Offering is subject to market conditions, and there can be no assurance as to whether or when the Offering may be completed, or as to the actual size or terms of the Offering.
The Company intends to use the net proceeds of the Offering for pre-commercialization and launch activities, as well as working capital and general corporate purposes.
Posted on 12/9/19 at 7:56 am to bayoubengals88
Down 7% premarket.. also we now know that ILJIN dropped 20% of its shares during Nov/Dec
Posted on 12/9/19 at 7:57 am to jmcwhrter
quote:It's always those bastards
ILJIN dropped 20% of its shares during Nov/Dec
Posted on 12/9/19 at 8:03 am to jmcwhrter
AUPH is actually up premarket-as of now
Posted on 12/9/19 at 8:11 am to thatguy777
quote:Yeah, can you believe it?! I was actually hoping to go long on cheap calls.
AUPH is actually up premarket-as of now
Page 28 of 167
Popular
Back to top
Follow TigerDroppings for LSU Football News